Search research articles
Contact Us
Filters
Showing results (181-190 of 418) with videos related to
Page
of 42
Sort By:
Journal of the National Cancer Institute
|
September 11, 2021
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials
Fabio Efficace, David Cella, Neil K Aaronson, et al.
ESMO Open
|
November 15, 2018
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)
Maria Vittoria Dieci, Francesco Massari, Raffaele Giusti, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
Rosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology
|
April 29, 2014
Treatment of small cell lung cancer
Alessandro Morabito, Guido Carillio, Gennaro Daniele, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 11, 2023
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma
Marco Tagliamento, Massimo Di Maio, Jordi Remon, et al.
The Oncologist
|
November 8, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study
Alessandra Fabi, Maria Cecilia Cercato, Alessandro Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2020
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Chiara Cremolini, Carlotta Antoniotti, Alexander Stein, et al.
Expert Opinion on Therapeutic Targets
|
July 9, 2025
NRG/ErbB signaling: on the trail of a molecular fingerprint in mucinous carcinoma
Domenico Trombetta, Federico Pio Fabrizio, Massimo Di Maio, et al.
Cancers
|
March 13, 2024
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study
Maria Valentina Mussa, Sarah Allegra, Tiziana Armando, et al.
American Journal of Clinical Oncology
|
September 5, 2020
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)
Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, et al.
Page
of 42
Search research articles
Search
Showing results (181-190 of 418) with videos related to
Sort By:
Page
of 42
Journal of the National Cancer Institute
|
September 11, 2021
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials
Fabio Efficace, David Cella, Neil K Aaronson, et al.
ESMO Open
|
November 15, 2018
Gender influence on professional satisfaction and gender issue perception among young oncologists. A survey of the Young Oncologists Working Group of the Italian Association of Medical Oncology (AIOM)
Maria Vittoria Dieci, Francesco Massari, Raffaele Giusti, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
Rosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Critical Reviews in Oncology/Hematology
|
April 29, 2014
Treatment of small cell lung cancer
Alessandro Morabito, Guido Carillio, Gennaro Daniele, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 11, 2023
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma
Marco Tagliamento, Massimo Di Maio, Jordi Remon, et al.
The Oncologist
|
November 8, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study
Alessandra Fabi, Maria Cecilia Cercato, Alessandro Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2020
Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer
Chiara Cremolini, Carlotta Antoniotti, Alexander Stein, et al.
Expert Opinion on Therapeutic Targets
|
July 9, 2025
NRG/ErbB signaling: on the trail of a molecular fingerprint in mucinous carcinoma
Domenico Trombetta, Federico Pio Fabrizio, Massimo Di Maio, et al.
Cancers
|
March 13, 2024
Self-Completion Questionnaire on Sleep Evaluation in Patients Undergoing Oxaliplatin Therapy: An Observational Study
Maria Valentina Mussa, Sarah Allegra, Tiziana Armando, et al.
American Journal of Clinical Oncology
|
September 5, 2020
Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study)
Pierangela Sepe, Antonia Martinetti, Alessia Mennitto, et al.
Page
of 42